Kaposi sarcoma herpesvirus induces HO-1 during de novo infection of endothelial cells via viral miRNA-dependent and -independent mechanisms

mBio

Volumn 6, Issue 3, 2015, Pages

  Botto, Sara ^a   Totonchy, Jennifer E ^b   Gustin, Jean K ^a   Moses, Ashlee V ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; MICRORNA; MICRORNA K12 11; PROTEIN BACH1; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; HMOX1 PROTEIN, HUMAN;

ADULT; ARTICLE; BACH1 GENE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME INDUCTION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE TARGETING; HERPES VIRUS INFECTION; HERPESVIRIDAE; HO 1 CELL; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA HERPESVIRUS; KAPOSI SARCOMA HERPESVIRUS INFECTION; KINETICS; LYMPH VESSEL ENDOTHELIUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SPINDLE CELL; STEM CELL; UPREGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS MUTANT; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN HERPESVIRUS 8; METABOLISM; PHYSIOLOGY; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

ENDOTHELIAL CELLS; GENE DELETION; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; MICRORNAS; RNA, VIRAL; UP-REGULATION; VIRUS LATENCY;

EID: 84936970607     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00668-15     Document Type: Article

References (65)

1. Wen KW, Damania B. 2010. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett 289:140-150. http://dx.doi.org/10.1016/j.canlet.2009.07.004.
2. Mesri EA, Cesarman E, Boshoff C. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10:707-719. http://dx.doi.org/10.1038/ nrc2888.
3. Martin D, Gutkind JS. 2008. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 27(Suppl 2): S31-S42. http://dx.doi.org/10.1038/onc.2009.351.
4. GanemD. 2012. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol Mech Dis 1:1-26. http://dx.doi.org/10.1146/ annurev.pathol.1.110304.100133.
5. Giffin L, Damania B. 2014. KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res 88:111-159. http://dx.doi.org/10.1016/B978-0-12-800098-4.00002-7.
6. Lee H-R, Brulois K, Wong L, Jung JU. 2012. Modulation of immune system by Kaposi's sarcoma-associated herpesvirus: lessons from viral evasion strategies. Front Microbiol 3:44. http://dx.doi.org/10.3389/ fmicb.2012.00044.
7. McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Früh K, Moses AV. 2004. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHVinfected endothelial cells. Blood 103:3465-3473. http://dx.doi.org/10.1182/ blood-2003-08-2781.
8. Raggo C, Ruhl R, McAllister S, Koon H, Dezube BJ, Früh K, Moses AV. 2005. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res 65:5084-5095. http://dx.doi.org/10.1158/0008-5472.CAN-04-2822.
9. Abraham NG, Kappas A. 2008. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127. http://dx.doi.org/10.1124/ pr.107.07104.
10. Banerjee P, Basu A, Wegiel B, Otterbein LE, Mizumura K, Gasser M, Waaga-Gasser AM, Choi AM, Pal S. 2012. Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis-and autophagy-regulating molecules. J Biol Chem 287:32113-32123. http:// dx.doi.org/10.1074/jbc.M112.393140.
11. Gozzelino R, Jeney V, Soares MP. 2010. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50:323-354. http:// dx.doi.org/10.1146/annurev.pharmtox.010909.105600.
12. Miyazaki T, Kirino Y, Takeno M, Samukawa S, Hama M, Tanaka M, Yamaji S, Ueda A, Tomita N, Fujita H, Ishigatsubo Y. 2010. Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach 1. Cancer Sci 101:1409-1416. http:// dx.doi.org/10.1111/j.1349-7006.2010.01550.x.
13. Do MT, Kim HG, Khanal T, Choi JH, Kim DH, Jeong TC, Jeong HG. 2013. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. Toxicol Appl Pharmacol 271:229-238. http://dx.doi.org/ 10.1016/j.taap.2013.05.010.
14. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW, Friess H. 2005. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11:3790-3798. http://dx.doi.org/10.1158/ 1078-0432.CCR-04-2159.
15. Lin P-H, Lan W-M, Chau L-Y. 2013. TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation. Oncogene 32:2325-2334. http://dx.doi.org/10.1038/onc.2012.244.
16. Ryter SW, Alam J, Choi AM. 2006. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583-650. http://dx.doi.org/10.1152/physrev.00011.2005.
17. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. 2010. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80:1895-1903. http://dx.doi.org/10.1016/ j.bcp.2010.07.014.
18. Ferrándiz ML, Devesa I. 2008. Inducers of heme oxygenase-1. Curr Pharm Des 14:473-486. http://dx.doi.org/10.2174/138161208783597399.
19. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5.
20. Grey F, Hook L, Nelson J. 2008. The functions of herpesvirus-encoded microRNAs. Med Microbiol Immunol 197:261-267. http://dx.doi.org/ 10.1007/s00430-007-0070-1.
21. Gottwein E. 2012 Kaposi's sarcoma-associated herpesvirus microRNAs. Front Microbiol 3:165. http://dx.doi.org/10.3389/fmicb.2012.00165.
22. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 1096-1099. http://dx.doi.org/10.1038/nature05992.
23. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R. 2007. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81:12836-12845. http://dx.doi.org/ 10.1128/JVI.01804-07.
24. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, Igarashi K. 2002. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21:5216-5224. http://dx.doi.org/ 10.1093/emboj/cdf516.
25. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, Wasserman WW, Biswal S. 2010. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38:5718-5734. http://dx.doi.org/10.1093/nar/ gkq212.
26. Shan Y, Lambrecht RW, Donohue SE, Bonkovsky HL. 2006. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J 20:2651-2653. http://dx.doi.org/10.1096/fj.06-6346fje.
27. Warnatz H-J, Schmidt D, Manke T, Piccini I, Sultan M, Borodina T, Balzereit D, Wruck W, Soldatov A, Vingron M, Lehrach H, Yaspo ML. 2011. The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J Biol Chem 286:23521-23532. http://dx.doi.org/10.1074/jbc.M111.220178.
28. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. 2002. A complex with chromatin modifiers that occupies E2F-and Mycresponsive genes in G0 cells. Science 296:1132-1136. http://dx.doi.org/ 10.1126/science.1069861.
29. Sun J, Brand M, Zenke Y, Groudine M, Igarashi K. 2004. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci U S A 101:1461-1466. http://dx.doi.org/10.1073/pnas.0308083100.
30. Elton TS, Selemon H, Elton SM, Parinandi NL. 2013. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532: 1-12. http://dx.doi.org/10.1016/j.gene.2012.12.009.
31. Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R. 2011. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice. J Virol 85:9877-9886. http://dx.doi.org/10.1128/ JVI.05558-11.
32. Sin S-H, Kim YB, Dittmer DP. 2013. Latency locus complements microRNA 155 deficiency in vivo. J Virol 87:11908-11911. http://dx.doi.org/ 10.1128/JVI.01620-13.
33. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM. 2012. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the Toll-like receptor/ interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol 86:11663-11674. http://dx.doi.org/10.1128/JVI.01147-12.
34. Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D, Romano M, Kearney P, Oates J, Plaisance K, Renne R, Kaleeba J, Parsons C. 2010. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog 6:e1000742. http://dx.doi.org/10.1371/ journal.ppat.1000742.s004.
35. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
36. Cancian L, Hansen A, Boshoff C. 2013. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming. Trends Cell Biol 23:421-432. http://dx.doi.org/10.1016/ j.tcb.2013.04.001.
37. Chang H, Ganem D. 2013. A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads tomTORC1activation and rapamycin sensitivity. Cell Host Microbe 13:429-440. http:// dx.doi.org/10.1016/j.chom.2013.03.009.
38. Hong Y-K, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR, Libermann T, Dezube BJ, Fingeroth JD, DetmarM. 2004. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36:683-685. http://dx.doi.org/10.1038/ng1383.
39. Wang H-W, Trotter MW, Lagos D, Bourboulia D, Henderson S, Mäkinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687-693. http://dx.doi.org/10.1038/ng1384.
40. Carroll PA, Brazeau E, Lagunoff M. 2004. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 328:7-18. http://dx.doi.org/10.1016/ j.virol.2004.07.008.
41. Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, Zhu L, Chandran B, Nelson JA. 1999. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 73:6892-6902.
42. Gottlieb Y, Truman M, Cohen LA, Leichtmann-Bardoogo Y, Meyron-Holtz EG. 2012. Endoplasmic reticulum anchored heme-oxygenase-1 faces the cytosol. Haematologica 97:1489-1493. http://dx.doi.org/ 10.3324/haematol.2012.063651.
43. Gallaher AM, Das S, Xiao Z, Andresson T, Kieffer-Kwon P, Happel C, Ziegelbauer J. 2013. Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis. PLoS Pathog 9:e1003584. http://dx.doi.org/10.1371/ journal.ppat.1003584.
44. Plaisance-Bonstaff K, Choi HS, Beals T, Krueger BJ, Boss IW, Gay LA, Haecker I, Hu J, Renne R. 2014. KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors. Viruses 6:4005-4023. http://dx.doi.org/10.3390/v6104005.
45. Skalsky RL, Cullen BR. 2010. Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123-141. http://dx.doi.org/10.1146/ annurev.micro.112408.134243.
46. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1842-1849.
47. Lin X, Li X, Liang D, Lan K. 2012. MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions. J Virol 86: 12717-12730. http://dx.doi.org/10.1128/JVI.01473-12.
48. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK. 2005. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants*. J Biol Chem 280:16891-16900. http://dx.doi.org/10.1074/jbc.M500166200.
49. Lee Y-M, Auh Q-S, Lee D-W, Kim JY, Jung HJ, Lee SH, Kim EC. 2013. Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells. Biomed Res Int 2013:210604. http://dx.doi.org/10.1155/2013/210604.
50. Inamdar NM, Ahn YI, Alam J. 1996. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem Biophys Res Commun 221:570-576. http://dx.doi.org/ 10.1006/bbrc.1996.0637.
51. Zhang J, Ohta T, Maruyama A, Hosoya T, Nishikawa K, Maher JM, Shibahara S, Itoh K, Yamamoto M. 2006. BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress. Mol Cell Biol 26:7942-7952. http://dx.doi.org/10.1128/MCB.00700-06.
52. Gjyshi O, Bottero V, Veettil MV, Dutta S, Singh VV, Chikoti L, Chandran B. 2014. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection. PLoS Pathog 10:e1004460. http://dx.doi.org/ 10.1371/journal.ppat.1004460.
53. Chandran B. 2010. Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J Virol 84:2188-2199. http://dx.doi.org/ 10.1128/JVI.01334-09.
54. Coen N, Duraffour S, Topalis D, Snoeck R, Andrei G. 2014. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against γ-herpesviruses. Antimicrob Agents Chemother 58:7312-7323. http://dx.doi.org/10.1128/AAC.03957-14.
55. Dittmer DP, Krown SE. 2007. Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus. Curr Opin Oncol 19:452-457. http://dx.doi.org/10.1097/CCO.0b013e3281eb8ea7.
56. Wang L, Damania B. 2008. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res 68:4640-4648. http://dx.doi.org/10.1158/0008-5472.CAN-07-5988.
57. Dittmer DP, Damania B. 2013. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)-an update. Curr Opin Virol 3:238-244. http:// dx.doi.org/10.1016/j.coviro.2013.05.012.
58. Orenstein JM. 2008. Ultrastructure of Kaposi sarcoma. Ultrastruct Pathol 32:211-220. http://dx.doi.org/10.1080/01913120802343871.
59. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. http:// dx.doi.org/10.1016/j.jviromet.2011.03.012.
60. Stürzl M, Gaus D, Dirks WG, Ganem D, Jochmann R. 2013. Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line. Int J Cancer 132: 1954-1958. http://dx.doi.org/10.1002/ijc.27849.
61. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240. http://dx.doi.org/10.1016/j.virol.2004.03.049.
62. Ellison TJ, KedesDH. 2014. Variable episomal silencing of a recombinant herpesvirus renders its encoded GFP an unreliable marker of infection in primary cells. PLoS One 9:e111502. http://dx.doi.org/10.1371/ journal.pone.0111502.t002.
63. Jeffery HC, Wheat RL, Blackbourn DJ, Nash GB, Butler LM, Jeffery HC, Wheat RL, Blackbourn DJ, Nash GB, Butler LM. 2013. Infection and transmission dynamics of rKSHV.219 in primary endothelial cells. J Virol Methods 193:251-259. http://dx.doi.org/10.1016/ j.jviromet.2013.06.001.
64. Altschuler Y, Barbas SM, Terlecky LJ, Tang K, Hardy S, Mostov KE, Schmid SL. 1998. Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol 143:1871-1881. http://dx.doi.org/ 10.1083/jcb.143.7.1871.
65. Kramer MF, Coen DM. 2001. Enzymatic amplification of DNA by PCR: standard procedures and optimization. Curr Protoc Mol Biol Chapter 15:Unit 15.1. http://dx.doi.org/10.1002/0471142727.mb1510s95.